RhumbLine Advisers’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

RhumbLine Advisers’s Portfolio OXFD Stock Details OXFD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-32,488	Closed	-$560K	–	3037
2019 Q1	$560K	Sell	32,488 -270	-0.8%	-$4.27K	﹤0.01%	2285
2018 Q4	$419K	Buy	32,758 +11,022	+51%	+$167K	﹤0.01%	2382
2018 Q3	$353K	Sell	21,736 -11,125	-34%	-$159K	﹤0.01%	2434
2018 Q2	$424K	Buy	32,861 +10,320	+46%	+$139K	﹤0.01%	2377
2018 Q1	$281K	Buy	22,541 +2,595	+13%	+$31.6K	﹤0.01%	2470
2017 Q4	$279K	Sell	19,946 -4,079	-17%	-$59.8K	﹤0.01%	2500
2017 Q3	$404K	Sell	24,025 -475	-2%	-$7.73K	﹤0.01%	2416
2017 Q2	$412K	Buy	24,500 +2,053	+9%	+$30.7K	﹤0.01%	2399
2017 Q1	$348K	Buy	22,447 +1,074	+5%	+$15.3K	﹤0.01%	2432
2016 Q4	$320K	Sell	21,373 -3,407	-14%	-$47.8K	﹤0.01%	2461
2016 Q3	$311K	Buy	24,780 +600	+2%	+$6.02K	﹤0.01%	2469
2016 Q2	$218K	Buy	24,180 +5,850	+32%	+$57.3K	﹤0.01%	2693
2016 Q1	$182K	Buy	18,330 +110	+0.6%	+$1.13K	﹤0.01%	2761
2015 Q4	$210K	Buy	18,220 +1,860	+11%	+$23K	﹤0.01%	2773
2015 Q3	$221K	Buy	16,360 +630	+4%	+$8.54K	﹤0.01%	2735
2015 Q2	$218K	Buy	15,730 +2,650	+20%	+$35.8K	﹤0.01%	2845
2015 Q1	$184K	Buy	+13,080	New	+$178K	﹤0.01%	2852

Other funds holding OXFD

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

GPGA

Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

ECM

Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return

RhumbLine Advisers's OXFD Position: Q2 2019 in Review

RhumbLine Advisers sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q2 2019, closing a stake of 32,488 shares — an estimated $560K sold.

RhumbLine Advisers first reported a position in OXFD in Q1 2015 and held it in 17 quarters. The position peaked at $560K in Q1 2019. 86 funds tracked by Wall St. Rank hold OXFD as of Q2 2019.

RhumbLine Advisers reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q2 2019 after selling out during the quarter.
RhumbLine Advisers sold 32,488 Oxford Immunotec Global PLC Ordinary Shares shares in Q2 2019, an estimated $560K.
RhumbLine Advisers first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q1 2015 and held it in 17 quarters.
RhumbLine Advisers's Oxford Immunotec Global PLC Ordinary Shares position peaked at $560K in Q1 2019.
86 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q2 2019.

Based on RhumbLine Advisers's 13F filing for Q2 2019, filed 14 Aug 2019.